Nitrazepam Accord

Nitrazepam, the active ingredient in Nitrazepam Accord, is a benzodiazepine presented as an oral tablet for oral use. It is prescribed for the short‑term management of insomnia and for anxiety disorders in adult patients. Its pharmacological action enhances GABA‑mediated inhibition, producing sedative and anxiolytic effects.

GNH USA supplies Nitrazepam Accord as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Nitrazepam is used in the central nervous system to treat conditions that benefit from its sedative and anxiolytic properties.

- Insomnia: helps initiate and maintain sleep in patients with short‑term sleep disturbances. - Anxiety disorders: reduces excessive worry and tension in generalized anxiety. - Pre‑operative anxiety: provides a calming effect before surgical procedures.

Nitrazepam may cause a range of adverse reactions, which are grouped by frequency.

Common Side Effects: - Drowsiness: feeling unusually sleepy during the day. - Dizziness: sensation of light‑headedness or unsteadiness. - Fatigue: reduced energy and motivation. - Impaired coordination: difficulty with fine motor tasks. - Memory impairment: short‑term recall difficulties. - Headache: mild to moderate head pain.

Serious or Rare Side Effects: - Depression or suicidal thoughts: mood changes requiring immediate attention. - Respiratory depression: slowed breathing, especially with other depressants. - Severe skin reactions: rash, Stevens‑Johnson syndrome. - Anaphylaxis: acute allergic response with swelling and difficulty breathing. - Paradoxical reactions: agitation, aggression, or increased anxiety.

When prescribing nitrazepam, clinicians should consider several safety precautions to minimize risk.

- Assess renal and hepatic function: adjust use in patients with impairment. - Avoid abrupt discontinuation: taper dose to prevent withdrawal symptoms. - Use caution in elderly: increased sensitivity to sedation and falls. - Avoid alcohol and other CNS depressants: risk of excessive sedation. - Monitor for dependence and abuse: limit duration of therapy. - Store at room temperature: keep in original packaging, protect from moisture.

Nitrazepam can interact with other medicines, altering its effects or safety profile.

Major Interactions (Avoid): - CNS depressants (e.g., barbiturates, opioids): additive sedation and respiratory depression. - Alcohol: markedly increased drowsiness and impaired coordination. - Antifungal agents (e.g., ketoconazole): may raise nitrazepam plasma concentrations.

Moderate Interactions (Monitor Closely): - CYP3A4 inhibitors (e.g., erythromycin): possible increase in nitrazepam levels. - CYP3A4 inducers (e.g., carbamazepine): may reduce therapeutic effect. - Antidepressants (e.g., SSRIs): can enhance central nervous system depression.